Search for: "In re: Abbott Laboratories"
Results 61 - 80
of 216
Sorted by Relevance
|
Sort by Date
28 Sep 2010, 7:14 am
Meridia is produced by Abbott Laboratories and has been on the market since 1997. [read post]
29 May 2007, 5:10 am
Abbott Laboratories Inc., 444 F.3d 383 that the plaintiff there could bypass the "vaccine court" and litigate in the usual court for damages because the suit was against the makers of thimerosal, which, not being a vaccine, didn't fall under the protection of the legislation. [read post]
1 Sep 2011, 2:39 am
September 22, 2011 - 2 PM: Abbott Laboratories v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas)… [read post]
15 Sep 2015, 6:17 pm
Abbott Laboratories, Inc., No. 1:13-cv-144, slip op. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
16 Apr 2020, 8:30 am
Attorney Jay Lefkowitz prepared for his argument in Abbott Laboratories, the first case argued under the Supreme Court's new remote argument rules, by participating in two mock argument sessions, one by phone and one by video conference. [read post]
22 Apr 2014, 7:41 am
Procedural HistoryThe New Drug Application (NDA) for the Tarka® product was approved by the Food and Drug Administration in 1996 and acquired by Abbott Laboratories in 2001. [read post]
6 Dec 2010, 6:06 am
" Now, here's the Times: Word quickly reached top executives at Abbott Laboratories that a Baltimore cardiologist, Dr. [read post]
6 Dec 2010, 6:06 am
" Now, here's the Times: Word quickly reached top executives at Abbott Laboratories that a Baltimore cardiologist, Dr. [read post]
15 Sep 2010, 2:40 am
Highlights this week included: 2nd Circuit denies en banc reconsideration in Cipro case: In re Ciprofloxacin Antitrust Litigation (Patent Docs) (FDA Law Blog) (IPBiz) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
13 Aug 2015, 10:56 am
Forest Laboratories, plaintiffs alleged that defendant manufacturer of brand-name antidepressant Lexapro omitted material efficacy information from the drug label in violation of California’s consumer protection laws. [read post]
1 Oct 2010, 5:25 am
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
12 Sep 2012, 1:46 pm
Supreme Court’s decision in Blonder-Tongue Laboratories, Inc. v. [read post]
5 Jan 2011, 1:34 am
General AUTM’s 2010 Better World Report highlights (PatentlyBIOtech) Drug R&D advocate named Kenyan ambassador to UN Geneva (IP Watch) US: Patent eligibility and In re Grams (Patent Docs) US: Main Hastings files false marking complaint against Pfizer based on products from its animal health division (Patent Docs) US: IDEXX files patent infringement complaint against Abbott Laboratories based on its sale of Architect HIV Ag/Ab Combo assay (Patent Docs) US: Life… [read post]
12 May 2015, 7:35 am
We're not Canadian lawyers, so we gladly outsource Canadian developments to those who are, such as these guys - Mike A. [read post]
16 Aug 2018, 6:38 pm
Antitrust Litig.,551 F.2d 213, 219 (8th Cir. 1997))).(...)We ruled in Abbott Laboratories v. [read post]
19 Sep 2014, 3:00 am
The Eighth Circuit found that the dicta In re Abbott Laboratories, Inc., 698 F.3d 568 (7th Cir. 2012) applied to this case. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI decision… [read post]
